NORDEA INVESTMENT MANAGEMENT AB - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORDEA INVESTMENT MANAGEMENT AB ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,253,877
-2.3%
158,571
-2.6%
0.01%0.0%
Q2 2023$3,331,129
-8.1%
162,772
-25.0%
0.01%0.0%
Q1 2023$3,622,832
-22.1%
217,066
-9.1%
0.01%
-28.6%
Q4 2022$4,647,710
+25.1%
238,834
-2.8%
0.01%
+16.7%
Q3 2022$3,714,000
+19.5%
245,637
-0.5%
0.01%
+20.0%
Q2 2022$3,109,000
-30.2%
246,768
-9.5%
0.01%
-16.7%
Q1 2022$4,456,000
-28.5%
272,731
+1.1%
0.01%
-14.3%
Q4 2021$6,232,000
-23.9%
269,804
-0.9%
0.01%
-36.4%
Q3 2021$8,193,000
+3.0%
272,268
+51.5%
0.01%0.0%
Q2 2021$7,958,000179,6830.01%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders